Life Sciences Vital for Economic RecoveryLONDON - The Association of British Pharmaceutical Industry (ABPI) will be launching their manifesto ‘Prescription for Innovation’ on Monday 14 September at Imperial College. The manifesto will be launched by Chris Brinsmead, President of the ABPI, in partnership with Richard Lambert of the CBI, Professor Steve Smith of Imperial and Ade Adeagbo of patients’ organisation National Voices. Results From Improve Study Show MRI Benefits of Rebif(R) Seen Early in Relapsing-Remitting Multiple Sclerosis Treatment and Sustained Over TimeGENEVA - - Data Presented at the 25th Congress of the European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMS) Held in Dusseldorf, Germany, From September 9-12, 2009. New Research Indicates 95% of Patients are in Moderate to Severe Chronic Pain Despite One Year of TreatmentEUROPEAN FEDERATION OF CHAPTERS OF THE INTERNATIONAL ASSOCIATION FOR THE STUDY OF PAIN (EFIC) CONGRESS, LISBON - Milliman Estimates Impact of Swine Flu on Employer Revenue and ProfitsLONDON - Modelling carried out by Milliman actuaries estimates that a severe swine flu pandemic has the potential to reduce a typical UK employer’s revenue by 4%-5% and its profit rate by five to six percentage points during the quarter of the pandemic. Dutch Top Institute Pharma Attracts International InterestLEIDEN, The Netherlands - The Danish Council for Strategic Research is visiting the Dutch Top Institute Pharma (TI Pharma) on Thursday, September 10. The purpose of their visit is to learn about the unique Dutch approach on public-private cooperation and the concrete results that are being booked by this institute. In the past, in the European Council, Denmark has cited TI Pharma as a prime example of public-private collaboration in the pharmaceutical sector and is considering following its lead. arGEN-X Raises EUR9.5 Million to put SIMPLE Antibody(TM) Platform to WorkROTTERDAM, The Netherlands - arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody(TM) platform, today announced the successful first closing of its Series A equity financing round. The Company raised EUR 9.5million (~ USD 13.6 million) from a syndicate of leading life science investors. The financing round is one of the largest of its kind in the last 12 months. PharmaVentures Corporate Advisory Appoints Nikki Watkins as Practice Head, Product & Portfolio StrategyOXFORD, England - PharmaVentures announced today the appointment of Nikki Watkins as Head of the Product & Portfolio Strategy Practice of Corporate Advisory, leading a team of Senior Advisors and Analysts. Elsevier Joins InChI Trust as a Charter MemberNEUCHATEL, Switzerland - Elsevier, a leading publisher of scientific, technical and medical information products and services, today announced it has become one of the Charter Members of the InChI Trust and will have a seat on the board at the first InChI Trust Board meeting on September 11th. Pergamum to Provide Effective Development of Innovative Dermatology and Wound Healing CompaniesSTOCKHOLM - Pergamum AB has announced its formation; Pergamum will commercialize the Karolinska Development dermatology and wound healing interests, and create a broad-based therapeutic company in its focus areas. Linda Dyson Joins Cohn & Wolfe as Global Healthcare Practice LeaderNEW YORK - Cohn & Wolfe, a leading global public relations agency, today announced that Linda Dyson has joined the firm as Executive Vice President and Global Healthcare Practice leader. She will report to Donna Imperato, CEO of Cohn & Wolfe. WCC Smart Search & Match and Priv-ID Announce Global CollaborationUTRECHT, The Netherlands - - Powerful Multi-Modal Fusion Platform Powers Privacy-Enhancing Biometric Technology PRA International Chairs Session on Post Marketing Safety IssuesRALEIGH, North Carolina - - PRA Experts Present at the World Drug Safety Congress PRA International, a leading Clinical Research Organization, will chair and present at a session during the Third Annual World Drug Safety Congress to be held in London on 16-17 September, 2009. The Congress is a gathering of leading Safety, Risk Management and Pharmacovigilance professionals. On 16 September, Dr. Sabine Richter, PRA’s Vice President of Safety and Risk Management, will chair a session on Post Marketing Safety Strategy. In this session, Mark Nelson Tyrrell, BS, RPh, Director, Safety and Risk Management at PRA, will present: Post-Marketing Safety Surveillance Design: Choices and Implementation. Helix BioPharma Closes Private PlacementAURORA, Ontario - Helix BioPharma Corp. (TSX, FSE: “HBP”; OTCQX: “HXBPF”) today announced that it has closed its previously announced private placement of 6,625,000 units at US$2.05 per unit. realbuzz.com Top 25 Things to do Before You DieLONDON - Have you ever thought about what you want to do before you die? The 2007 film The Bucket List highlighted this with Jack Nicholson, and Morgan Freeman. With the bucket list being effectively your list of things you want to achieve before you die. So, do you want to Climb a mountain, drive a Ferrari, run a marathon? Or just simply make a million… First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer PainLISBON, Portugal - - Choosing a More Appropriate Route of Administration for Fast Acting Pain Relief Could be the key to Improvement New Chief Executive Officer and Vice President Commercial Operations USA at the Helsinn Group’s American subsidiary, Helsinn Therapeutics (U.S.) Inc.LUGANO, Switzerland - As part of the Helsinn Group’s development strategy, William Mann, PhD, has been appointed as new CEO in the American subsidiary, Helsinn Therapeutics (U.S.) Inc. William Mann, PhD, was already Chief Operating Officer of the recently acquired Helsinn Therapeutics, and has held leadership positions in a Swiss multinational with positions in Business Development and in Research. Clinical Therapeutics Announces the Addition of Michael G. Spigarelli, MD, PhD, as Editor for a Refocused Pediatric, Adolescent, & Maternal Therapeutics SectionBRIDGEWATER, England - Clinical Therapeutics,( www.clinicaltherapeutics.com/) the world’s premier, rapid-publication journal, is proud to announce the addition of Michael G. Spigarelli, MD, PhD, to our distinguished editorial board. 2009 India Excellence in Healthcare AwardsMUMBAI, India - - Annual India Excellence in Healthcare Awards to Celebrate Best in the Industry Relaunched Healthcare Republic Provides the Best Online Resources for Primary Care PractitionersLONDON - Users of leading primary care website Healthcare Republic ( www.healthcarerepublic.com/) will now find it easier than ever to find drug and research updates, archived articles and breaking news from all of Haymarket’s medical publications. VantagePoint Venture Partner’s Portfolio Companies Take Top Rankings in Guardian’s Global CleanTech 100SAN BRUNO, California - - Three Portfolio Companies Included in Top 10, 13 in Top 100 VantagePoint Venture Partners is pleased to announce that a majority of the firm’s clean technology investments have been recognized as leaders by The Guardian, a London-based media group, in its annual 100 Global CleanTech Companies rankings. Karolinska Development Introduces New Concept for Development of its Dermatology and Wound Healing PortfolioSTOCKHOLM - Karolinska Development (publ) have announced the formation of Pergamum AB, a company that will commercialize its dermatology and wound healing opportunities as associated business units within one company. Karolinska Development has transferred all of its holdings from its five dermatology and wound healing companies to Pergamum AB, owning 64% of the new company. Tata Interactive Systems Initiates Vertical-Focused Learning Solutions for Health Care, Pharmaceutical, and BiotechnologyMUMBAI, India - - Tata Interactive Systems Announces its First Domain-Specific Learning and Consulting Solutions for Health Care MitraClip(R) Therapy Introduced in AustriaMENLO PARK, California - - Use of the MitraClip(R) System Continues to Expand in Europe /C O R R E C T I O N — Clinical Therapeutics/BRIDGEWATER, New Jersey - In the news release, “Clinical Therapeutics Announces the Addition of Michael G. Spigarelli, MD, PhD, as Editor for a Refocused Pediatric, Adolescent, & Maternal Therapeutics Section” issued on 9 Sep 2009 08:30 GMT, by Clinical Therapeutics over PR Newswire, we are advised by a representative of the company that the Dateline has been changed from “Bridgewater, England” to “Bridgewater, New Jersey” and the contact number has been changed from +44(0)908-547-2094 to +1-908-547-2094 which were incorrectly transmitted by PR Newswire. Complete, corrected release follows: /C O R R E C T I O N — Nycomed/LISBON, Portugal - In the news release, “First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain” issued on 9 Sep 2009 07:00 GMT, by Nycomed over PR Newswire, we are advised by a representative of the company that the first set of bullet points should read “The median number of BTCP episodes per patient per day was 3; Each episode had a median duration of 60 minutes; 96% of the pain episodes were described as moderate to severe; For 90% of patients their BTCP interfered with their daily living including their ability to sleep, walk and get on with other people” and the second set of bullet points should read “At least 95% of patients were using orally administered drugs; “The time to first noticing a reduction in pain had a median time of 20 minutes; In this survey the median time to peak effect of the current BTCP rescue medications was 30 minutes”. In addition, the fourth paragraph should read “For this kind of pain episode the ideal treatment would be fast acting with a short duration of action to most closely match the nature of BTCP episodes” instead of “For this kind of pain episode the ideal treatment would be fast acting with short duration of action to most closely match the nature of BTCP episodes” as incorrectly transmitted by PR Newswire. Complete, corrected release follows: The Mind Games Smokers Play When Trying to Quit Revealed in New SurveyLONDON - LONDON, September 8 /PRNewswire/ – - New NiQuitin(R) Pre-Quit(TM) Lozenges Launched To Help Smokers Address Their Internal Struggle By Easing Into Quitting Oprah’s Long Time Make-Up Artist Throws a HissyfitMELBOURNE, Australia - Reggie Wells, the Emmy award winning make-up artist, who has been the man behind the face of global media sensation Oprah Winfrey for more than 20 years, has been appointed International Creative Director of Australia’s hottest new beauty brand, Hissyfit. Frost & Sullivan Global Heart Health Ingredients Excellence in Financial & Risk Management Award Conferred on Pronova BioPharmaLONDON - The 2009 Frost & Sullivan Global Heart Health Ingredients Excellence in Financial & Risk Management Award is presented to Pronova BioPharma ASA. The company’s first commercialised product is the first and only EU-and FDA-approved omega-3 derived prescription drug. Branded Omacor in Europe and Asia and Lovaza in the USA, the product is a prescribed adjunct to diet for the treatment of elevated levels of triglycerides in humans. In addition, Omacor/Lovaza has the approval in certain markets for treatment of the secondary prevention of post-myocardial infarction. LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus ChallengeBOZEMAN, Montana - LigoCyte Pharmaceuticals, Inc. announced today that it has initiated its third human clinical trial of its norovirus vaccine. The Phase I/II study will assess safety and immunogenicity associated with LigoCyte’s investigational, nasally-delivered, dry powder vaccine in healthy adults. The study will also assess potential protection against clinical symptoms of norovirus infection by including a live virus challenge of subjects that have received either the vaccine or placebo. Clinical studies to date have shown the vaccine to be immunogenic and generally well tolerated in human subjects. Update on Velaglucerase AlfaCAMBRIDGE, Massachusetts - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, is committed to doing everything possible to assist Gaucher patients and their physicians during the imiglucerase supply shortage. Shire is pleased to be able to provide velaglucerase alfa well over a year ahead of previously anticipated commercial launch world wide. Cell Biosciences Signs Agreement to Acquire Alpha InnotechSANTA CLARA, California - Cell Biosciences, Inc. and Alpha Innotech Corp. (OTC Bulletin Board: APNO) today announced that they have entered into a definitive agreement providing for the acquisition of Alpha Innotech by Cell Biosciences for US$1.50 per share or approximately US$17.9 million in cash. This acquisition would significantly expand Cell Biosciences’ protein analysis business to include a global infrastructure and a broad protein analysis product portfolio. 50 Millionth Unique Chemical Substance Recorded in CAS REGISTRY(SM)COLUMBUS, Ohio - - Novel analgesic marks major milestone in scientific discovery Chemical Abstracts Service (CAS) (www.cas.org/), a division of the American Chemical Society, announced that on September 7 it recorded the 50 millionth substance in CAS REGISTRY, the world’s most comprehensive and high-quality compendium of publicly disclosed chemical information. The recently registered substance is a novel arylmethylidene heterocycle with analgesic properties. Reaching the 50 million mark so quickly is an indicator of the accelerating pace of scientific knowledge. CAS registered the 40 millionth substance just nine months ago - in contrast, it took 33 years for CAS to register the 10 millionth compound in 1990. Founder of Curidium Launches Elixior, an Advisory Company Focused on the Development and Growth of Innovative Personalized Medicine BusinessesLONDON - Elixior Limited, the advisory company focused on the development and growth of innovative personalized medicine businesses, announced today its launch by the founder and former CEO of Curidium, Dr Anne Bruinvels. OAG Releases Prototype for Pandemic Disease Planning and ManagementCHICAGO - - Modelling Air Travel Could Prove Critical for Health Organizations and Government Agencies Preparing for the Upcoming Flu Season Bounty Parenting Club Launches View on Demand ‘How to Breastfeed’ VideoLONDON - Bounty, the UK’s favourite parenting club, today launches a 4 minute ‘How to Breastfeed’ online video clip to help expectant and new mums take a real life, close up peek at how a baby ‘latches on’ to the breast when feeding. |
